Newsroom
301 articles
WarningsChildren and young adults, particularly university students, remain at risk from meningococcal meningitis and septicaemia, conditions that, while rare, can be devastating, life-changing, and sometimes fatal. Latest data…
ImportantThe Saudi Food and Drug Authority (SFDA) has launched the National Network for Drugs and Medical Products Safety During Pregnancy and Breastfeeding. Unveiled at the Global Health Exhibition…
Trending topicsThe Saudi Food and Drug Authority (SFDA) has launched the Regulatory AI System for Incoming Drugs (RASID), a smart service utilizing artificial intelligence to regulate controlled medications carried…
WarningsDamaged capsules have been identified in batches of Lenalidomide Mylan, with powder visible inside the blister pocket. For all strengths and pack sizes, healthcare professionals should carefully inspect…
Drug ApprovalsOn October 24, 2025, the U.S. Food and Drug Administration approved Revumenib (Revuforj, Syndax Pharmaceuticals, Inc.), a menin inhibitor, for adult and pediatric patients aged 1 year and…
Drug ApprovalsOn October 23, 2025, the FDA approved belantamab mafodotin-blmf (Blenrep, GlaxoSmithKline), a targeted B-cell maturation antigen (BCMA) antibody-drug conjugate, in combination with bortezomib and dexamethasone (BVd) for adults…
Drug ApprovalsOn October 24, 2025, the Medicines and Healthcare products Regulatory Agency (MHRA) approved Concizumab (Alhemo) to prevent or reduce the frequency of bleeding episodes in people aged 12…
Trending topicsThe Saudi Food and Drug Authority (SFDA), led by CEO Dr. Hisham S. Aljadhey, has launched the Electronic Integration of Medications Risk Minimization Measures (RMMs) with several prominent…
ImportantThe CEO of the Saudi Food and Drug Authority (SFDA), Dr. Hisham S. Aljadhey, has introduced the Saudi Pharmacopoeia at the Global Health Exhibition in Riyadh (Held from…
WarningsThe Medicines and Healthcare products Regulatory Agency (MHRA) uncovered and shut down the UK’s first illegal weight loss medicine factory during a raid on a Northampton warehouse. This…
ImportantThe UK’s Innovative Licensing and Access Pathway (ILAP) aims to help patients get promising and much-needed new medicines more quickly. Announced by the Medicines and Healthcare products Regulatory…
Trending topicsThe Medicines and Healthcare products Regulatory Agency (MHRA) has launched three government-funded initiatives that aim to make medicine development and regulation safer and more efficient through the use…
Trending topicsArtificial intelligence (AI) continues to redefine the future of healthcare, from detecting cancer faster to improving diagnostic accuracy across hospitals. The UK’s Medicines and Healthcare products Regulatory Agency…
WarningsThe FDA is now raising awareness regarding administration of tranexamic acid injections to be limited only to intravenous administration. There have been case reports where tranexamic acid was…
ImportantEisai GmbH, in agreement with the European Medicines Agency (EMA), has updated the MRI monitoring schedule for LEQEMBI (lecanemab) 100 mg/mL concentrate for infusion, a treatment for early…
Talk to our experts and get tailored solutions to help you stay compliant and move forward with confidence.
Submit RFI/RFP
Request Consultation
Submit RFI/RFP